← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Advanced Vision Therapies, Inc.
Gaithersburg, MD
$4,349,990
Total funding
8
Grants
Funding over time
peak $1.6M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$4,349,990 · 8
By mechanism
R44$2,383,335 · 1
R43$1,966,655 · 7
Investigators at Advanced Vision Therapies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel Therapy for Wet Age-Related Macular Degeneration$1,095,601
R44 · FY2006 · EY
Novel Therapy for Wet Age-Related Macular Degeneration$1,064,532
R44 · FY2005 · EY
Evaluation of novel BIV-based vectors in vivo$541,836
R43 · FY2004 · EY
Novel Strategy for BIV Vector Site-Specific Integration$349,780
R43 · FY2006 · GM
Development of Novel BIV-based Lentiviral Vectors$329,702
R43 · FY2004 · GM
RdCVF as a novel therapeutic for retinitis pigmentosa$311,846
R43 · FY2005 · EY
Novel Therapy for Wet Age-Related Macular Degeneration$223,202
R44 · FY2004 · EY
Evaluation of Kininostatin for Treatment of Wet AMD$149,800
R43 · FY2005 · EY
A Novel BIV vector pseudotyped with thogoto virus gp75$149,800
R43 · FY2006 · GM
Novel Lentiviral Vector with Regulatable Gene Expression$133,891
R43 · FY2004 · EY